参考文章(141)
Young Rc, DeVita Vt, Glatstein E, Jaffe Es, Longo Dl, Ihde Dc, The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment. Seminars in Hematology. ,vol. 25, pp. 11- 16 ,(1988)
Hans Theodor Eich, Martina Heimann, Hartmut Stützer, Jan Kriz, Marcel Reiser, Rolf-Peter Müller, Long-term outcome and prognostic factors in early-stage nodal low-grade non-hodgkin's lymphomas treated with radiation therapy. Strahlentherapie Und Onkologie. ,vol. 185, pp. 288- 295 ,(2009) , 10.1007/S00066-009-1937-4
Oliver W. Press, Joseph M. Unger, Rita M. Braziel, David G. Maloney, Thomas P. Miller, Michael LeBlanc, Ellen R. Gaynor, Saul E. Rivkin, Richard I. Fisher, A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911. Blood. ,vol. 102, pp. 1606- 1612 ,(2003) , 10.1182/BLOOD-2003-01-0287
Pasquale Niscola, Massimo Magagnoli, Luigi Rigacci, Umberto Vitolo, Luigi Resegotti, Carola Boccomini, Vera Clò, Luca Baldini, Pier Luigi Zinzani, Teodoro Chisesi, Maura Brugiatelli, Massimo Federico, Antonio Cuneo, Gino Santini, Marina Liberati, Giampiero Bellesi, Vincenzo Pavone, Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases Blood. ,vol. 95, pp. 783- 789 ,(2000) , 10.1182/BLOOD.V95.3.783.003K33_783_789
Elias Campo, N Lee Harris, Elaine S Jaffe, Stefano A Pileri, Harald Stein, Jurgen Thiele, James W Vardiman, None, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues ,(2017)
Kirit M Ardeshna, Wendi Qian, Paul Smith, June Warden, Lindsay Stevens, Christopher FE Pocock, Fiona Miall, David Cunningham, John Davies, Jan Walewski, A. Burhan Ferhanoglu, Ken Bradstock, David C Linch, An Intergroup Randomised Trial of Rituximab Versus a Watch and Wait Strategy In Patients with Stage II, III, IV, Asymptomatic, Non-Bulky Follicular Lymphoma (Grades 1, 2 and 3a). A Preliminary Analysis Blood. ,vol. 116, pp. 6- 6 ,(2010) , 10.1182/BLOOD.V116.21.6.6
Y Bastion, C Sebban, F Berger, P Felman, G Salles, C Dumontet, P A Bryon, B Coiffier, Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients Journal of Clinical Oncology. ,vol. 15, pp. 1587- 1594 ,(1997) , 10.1200/JCO.1997.15.4.1587
C. D. Williams, C. N. Harrison, T. A. Lister, A. J. Norton, A. K. Blystad, B. Coiffier, G. Taghipour, N. Schmitz, A. H. Goldstone, , High-Dose Therapy and Autologous Stem-Cell Support for Chemosensitive Transformed Low-Grade Follicular Non-Hodgkin’s Lymphoma: A Case-Matched Study From the European Bone Marrow Transplant Registry Journal of Clinical Oncology. ,vol. 19, pp. 727- 735 ,(2001) , 10.1200/JCO.2001.19.3.727
Suzanne Rehn, Christer Sundström, Bengt Glimelius, Miriam Rodriguez, Håkan Ahlström, Predicting Malignancy Grade with PET in Non-Hodgkin's Lymphoma The Journal of Nuclear Medicine. ,vol. 36, pp. 1790- 1796 ,(1995)